Skip to main content

Heron Therapeutics, Inc 8-K, filed Nov 9, 2026

Heron Therapeutics, Inc. (HRTX)

8-K 2026-11-09 For: 2026-11-08
View Original
Added on November 09, 2026

About this 8-K

Heron Therapeutics, Inc filed this 8-K on November 9, 2026, reporting on events of November 8, 2026.

On November 8, 2026, Heron Therapeutics agreed to sell substantially all assets to CorMedix for $145.0 million cash, subject to closing-cash and net-working-capital adjustments, plus 14,583,333 CorMedix shares, subject to stockholder approval. AI summary

Items reported

  • Item 1.01: Entered into a material agreement
  • Item 3.03: Change to shareholders' rights
  • Item 7.01: Regulation FD disclosure
  • Item 9.01: Financial statements and exhibits